Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
Year-over-year total asset growth rate
Percentile
P72
Within normal range
vs 2Y Ago
0.9x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 10.80% |
| Q2 2025 | -7.40% |
| Q1 2025 | 0.94% |
| Q4 2024 | -12.01% |
| Q3 2024 | -9.30% |
| Q2 2024 | -10.01% |
| Q1 2024 | 22.36% |
| Q4 2023 | -12.77% |
| Q3 2023 | 11.41% |
| Q2 2023 | -6.96% |
| Q1 2023 | 13.51% |
| Q4 2022 | 3.18% |
| Q3 2022 | -8.02% |
| Q2 2022 | -6.29% |
| Q1 2022 | 54.46% |
| Q4 2021 | 63.50% |
| Q3 2021 | -11.62% |
| Q2 2021 | -8.64% |
| Q1 2021 | 33.73% |
| Q4 2020 | -13.48% |
| Q3 2020 | -7.65% |
| Q2 2020 | 12.15% |
| Q1 2020 | 73.28% |
| Q4 2019 | -13.15% |
| Q3 2019 | -16.07% |
| Q2 2019 | 263.07% |
| Q1 2019 | -19.10% |
| Q4 2018 | 11.94% |
| Q3 2018 | -9.39% |
| Q2 2018 | -18.61% |
| Q1 2018 | 29.28% |
| Q4 2017 | -19.18% |
| Q3 2017 | -8.77% |
| Q2 2017 | 5.62% |
| Q1 2017 | -21.40% |
| Q4 2016 | -30.12% |
| Q3 2016 | -11.08% |
| Q2 2016 | 3.60% |
| Q1 2016 | -10.26% |
| Q4 2015 | -7.59% |